FR-260330

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameFR-260330

Drug Alias NameiNOS inhibitor (Astellas)FR-260330FK-330

ClassificationSmall molecules

Mechanisms of ActionNitric oxide synthase, inducible inhibitors

TargetsNitric oxide synthase, inducible

Therapy Area/IndicationsRejection of organ transplantationInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsRejection of organ transplantationInflammation

ATC CodeN/A